Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis.

Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis.
复制标题

DOI:
10.3892/ol.2013.1626
复制
发表时间:
2013-12
期刊:
影响因子:
2.9
通讯作者:
Zhang Z
Zhang Z
中科院分区:
医学4区
文献类型:
--
作者:
Song J;Bai Z;Zhang J;Meng H;Cai J;Deng W;Bi J;Ma X;Zhang Z

文献摘要

参考文献

被引文献

相似文献

在胃癌 (GC) 患者中,循环 microRNA-21 (miR-21) 过度表达,可作为诊断生物标志物。在本研究中,假设血清miR-21表达水平与GC患者的预后相关。使用定量聚合酶链反应 (qPCR) 测定 103 名 GC 患者的血清 miR-21 表达水平。进行生存和 Cox 比例风险回归分析以确定患者血清 miR-21 表达水平与预后之间的相关性。分析患者血清miR-21水平与临床病理因素的相关性。血清 miR-21 表达水平高和低的组之间的生存曲线没有显着差异。血清中高水平的 miR-21 与肿瘤大小增加和 pT 分期晚期相关。这些发现表明,血清 miR-21 可作为监测 GC 患者肿瘤负荷的实用生物标志物。
In patients with gastric cancer (GC), circulating microRNA-21 (miR-21) is overexpressed and may serve as a diagnostic biomarker. In the present study, it was hypothesized that the serum miR-21 expression levels were associated with prognosis in the patients with GC. The expression levels of serum miR-21 were measured using quantitative polymerase chain reaction (qPCR) assays in 103 GC patients. Survival and Cox proportional-hazards regression analyses were performed to determine the correlation between serum miR-21 expression levels and prognosis in the patients. The correlation between the serum miR-21 levels and the clinicopathological factors of the patients was also analyzed. Survival curves were not significantly different between the groups exhibiting high and low levels of serum miR-21 expression. High levels of miR-21 in the serum were associated with an increased tumor size and an advanced pT stage. These findings suggest that serum miR-21 could be exploited as a practical biomarker for monitoring tumor burden in patients with GC.
DOI: 10.1158/0008-5472.can-09-1996
发表时间: 2009-10-15
期刊: Cancer research
影响因子: 11.2
作者:
Wang P;Zou F;Zhang X;Li H;Dulak A;Tomko RJ Jr;Lazo JS;Wang Z;Zhang L;Yu J
通讯作者: Yu J
DOI: 10.1038/sj.bjc.6605608
发表时间: 2010-03-30
影响因子: 8.8
作者:
通讯作者: --
DOI: 10.1007/s12032-012-0303-z
发表时间: 2012-12-01
期刊: MEDICAL ONCOLOGY
影响因子: 3.4
作者:
Le, Han-Bo;Zhu, Wang-Yu;Zhang, Yong-Kui
通讯作者: Zhang, Yong-Kui
DOI: 10.1016/j.bbrc.2009.03.077
发表时间: 2009-06-05
影响因子: 3.1
作者:
Li, Tao;Li, Dong;Huang, Yiran
通讯作者: Huang, Yiran
DOI: 10.1111/j.1365-2141.2008.07077.x
发表时间: 2008-06-01
影响因子: 6.5
作者:
Lawrie, Charles H.;Gal, Shira;Harris, Adrian L.
通讯作者: Harris, Adrian L.